Although blocking the VEGFA/KDR signaling with antibody therapy has been used for the treatment of cRCC for more than ten years, no immunohistochemical analysis of the expression and cellular localization of VEGFA and KDR proteins has been carried out. Here, VEGFA is linked to chromophobe renal cell carcinoma.